| Ytd | 25.75% | |
| 1y | 29.98% |
| Open | 5.35 | Prev Close | 5.34 | Low | 5.21 | High | 5.44 | Mkt Cap | 557.43M |
| Vol | 156.91K | Avg Vol | 166.39K | EPS | 0.47 | P/E | 11.53 | Forward P/E | 0.52 |
| Beta | 0.12 | Short Ratio | 0.62 | Inst. Own | 0.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 4.20 | 200-d Avg | 3.83 | 1yr Est | 11.00 |
Shares of SBC Medical Group Holdings Incorporated (NASDAQ: SBC - Get Free Report) hit a new 52-week
SBC Medical Group Holding (NASDAQ:SBC) held its second-quarter earnings conference call on Thursday.
SBC Medical Group Holding (NASDAQ:SBC) reported quarterly earnings of $0.11 per share which beat the
U.S. stock futures fall around 250 points on Monday. ASTS shares drop 13.5% after satellite placed i
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $1
SBC Medical Group Holding (NASDAQ:SBC) reported quarterly earnings of $0.14 per share which beat the
Stock futures mixed, investors may focus on Legence Corp, Unity Software, Carnival Corp, Argan Inc a
Stocks fall due to rising oil prices and failed Iran talks. Fear & Greed Index shows slight incr
Top Wall Street analysts changed outlook on top names. For all changes, including upgrades/downgrade
BTIG analyst Sam Eiber initiates coverage on SBC Medical Group Holding (NASDAQ:SBC) with a Buy ra
OrangeTwist, a leading U.S. med spa platform delivering cutting-edge aesthetic and wellness treatmen
SBC Medical Group Holdings Incorporated (NASDAQ:SBC) (the "Company"), a global provider of c
SBC Medical Group Holding (NASDAQ:SBC) reported quarterly earnings of $0.02 per share which missed t
SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"
SBC Medical Group Holdings (Headquarters: California, USA; CEO: Yoshiyuki Aikawa) hereby announces t
SBC Medical Group Holding (NASDAQ:SBC) reported quarterly earnings of $0.06 per share. The company
MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) announced a business alliance with SBC Medical Gro
Research published in the journal Addiction indicates that GLP-1 drugs like Ozempic may play a cruci